SII seeks permission from DCGI to make Sputnik V vaccine
Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission for the production of the COVID-19 vaccine Sputnik V in the country. The Pune-based company has also sought approval for test analysis and testing. Presently Dr. Reddy’s Laboratories is producing Russia’s Sputnik V vaccine in India. “The Serum Institute of India (SII) has submitted an application to the Drug Controller General of India (DCGI), seeking permission to manufacture the COVID-19 vaccine Sputnik V in India.” SII has already informed the government that it will In June, Covishield will produce and supply 10 crore doses. He is also making the Novavax vaccine. Regulatory approval for Novavax is yet to be received from the US. DCGI had approved its emergency use in April. A consignment of 30 lakh doses of Sputnik V reached Hyderabad on Tuesday.